Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) class II genes are expressed constitutively in only a few cell types, but they can be induced in the majority of them, in particular by interferon-gamma (IFN-gamma). The MHC class II transactivator gene CIITA is defective in a form of primary MHC class II deficiency. Here it is shown that CIITA expression is controlled and induced by IFN-gamma. A functional CIITA gene is necessary for class II induction, and transfection of CIITA is sufficient to activate expression of MHC class II genes in class II-negative cells in the absence of IFN-gamma. CIITA is therefore a general regulator of both inducible and constitutive MHC class II expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of PD-L1 and MHC II, which may cause exhaustion by binding to T-cell programmed cell death protein 1 (PD-1) and lymphocyte activation gene 3 (LAG-3), respectively, is regulated by tumor interferon (IFN) signaling.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [27]
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
Collins, T., Korman, A. J., Wake, C. T., Boss, J. M., Kappes, D. J., Fiers, W., Ault, K. A., Gimbrone, M. A., Strominger, J. L., & Pober, J. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4917 · Cited by 585
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Benoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., & Kerr, I. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06106.x · Cited by 411
Detection of a novel human class II HLA antigen
Watson, A. J., DeMars, R., Trowbridge, I. S., & Bach, F. H. (1983) · Nature · doi:10.1038/304358a0 · Cited by 376
Cited by
Items 301–400 of 899
Hellendall, R. P., & Ting, J. P. ‐. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00202-0 · Cited by 51
“Shuai et al., 1992; Steimle et al., 1994 and this is concordant with our findings that genistein inhibits class II MHC induction in brain glia.”
ResultA Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors
Wu, B., Liang, J., Yang, X., Fang, Y., Kong, N., Chen, D., & Wang, H. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c00569 · Cited by 46
Severe Combined Immunodeficiences: New and Old Scenarios
Aloj, G., Giardino, G., Valentino, L., Maio, F., Gallo, V., Esposito, T., Naddei, R., Cirillo, E., & Pignata, C. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2011.644607 · Cited by 50
“Transcriptional activity of MHC II genes is, however, not only dependent on these DNA-binding molecules but requires the cell type-specific [119] or inducible presence [120] of the transcriptional coactivator CIITA, called the “master regulator” [121].”
BackgroundYazawa, T., Ito, T., Kamma, H., Suzuki, T., Okudela, K., Hayashi, H., Horiguchi, H., Ogata, T., Mitsui, H., Ikeda, M., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64181-8 · Cited by 46
Direct role of NF‐κB activation in Toll‐like receptor‐triggered HLA‐DRA expression
Lee, K., Lee, Y., Kim, D., & Kwon, H. (2006) · European Journal of Immunology · doi:10.1002/eji.200535577 · Cited by 46
Mouse pancreatic beta cells express MHC class II and stimulate CD4 + T cells to proliferate
Zhao, Y., Scott, N. A., Quah, H. S., Krishnamurthy, B., Bond, F., Loudovaris, T., Mannering, S. I., Kay, T. W. H., & Thomas, H. E. (2015) · European Journal of Immunology · doi:10.1002/eji.201445378 · Cited by 52
Chan, M. M. P., Cheung, B. K. W., Li, J., Chan, L. L. Y., & Lau, A. S. Y. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708442 · Cited by 44
“APCs [ 51 , 52], the roles of IL-10 on HLA-DR surface expression on PBMo were investigated using flow cytometry.”
BackgroundMethodSisk, T. J. (2003) · International Immunology · doi:10.1093/intimm/dxg116 · Cited by 44
Brown, J. A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.18.4128 · Cited by 44
Single-cell analysis reveals insights into epithelial abnormalities in ovarian endometriosis
Yan, J., Zhou, L., Liu, M., Zhu, H., Zhang, X., Cai, E., Xu, X., Chen, T., Cheng, H., Liu, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113716 · Cited by 60
The Function of CD3+CD56+NKT-Like Cells in HIV-Infected Individuals
Jiang, Y., Cui, X., Chen, C., Zhang, J., Zhou, F., Zhang, Z., Fu, Y., Xu, J., Chu, Z., Liu, J., et al. (2014) · BioMed Research International · doi:10.1155/2014/863625 · Cited by 43
DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture
Majumder, P., & Boss, J. M. (2011) · Genes and Immunity · doi:10.1038/gene.2010.77 · Cited by 42
Xue, W., Metheringham, R. L., Brentville, V. A., Gunn, B., Symonds, P., Yagita∥, H., Ramage, J. M., & Durrant, L. G. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1169353 · Cited by 43
Codolo, G., Toffoletto, M., Chemello, F., Coletta, S., Teixidor, G. S., Battaggia, G., Munari, G., Fassan, M., Cagnin, S., & de Bernard, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02923 · Cited by 47
“…condition, we exposed M-CSF-differentiated macrophages with IFN-γ for 6 h before infecting or not the cells with the bacterium for 48 h. IFN-γ is a potent inducer of HLA-II expression and CIITA is the essential coactivator for both constitutive and IFN-γ -inducible HLA-II expression (18, 23, 24).”
MethodLi, J., Williams, M., Park, H. J., Bastos, H. P., Wang, X., Prins, D., Wilson, N. K., Johnson, C., Sham, K., Wantoch, M., et al. (2022) · Blood · doi:10.1182/blood.2021014009 · Cited by 41
Tang, K. C., Trzaska, K. A., Sv, S., Kotenko, S. V., Schwander, S., Ellner, J. J., & Rameshwar, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1826 · Cited by 47
Srisatjaluk, R. L., Doyle, R. J., & Justus, D. E. (1999) · Microbial Pathogenesis · doi:10.1006/mpat.1999.0287 · Cited by 43
Rohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · PubMed · Cited by 43
Gao, J., De, B. P., & Banerjee, A. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1411-1418.1999 · Cited by 43
“CIITA is the general regulator of MHC class II gene expression by IFN-g (39).”
BackgroundBinding and cooperative interactions between two B cell-specific transcriptional coactivators.
Fontes, J. D., Jabrane‐Ferrat, N., TOTH, C. R., & Peterlin, B. M. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2517 · Cited by 43
Kienes, I., Weidl, T., Mirza, N., Chamaillard, M., & Kufer, T. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031301 · Cited by 47
Engineering stem cells for cancer immunotherapy
Li, Y.-R., Zhou, Y., Kramer, A. B., & Yang, L. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.08.004 · Cited by 44
Muntasell, A., Carrascal, M., Álvarez, I., Serradell, L., van Veelen, P. A., Verreck, F. A. W., Koning, F., Abián, J., & Jaraquemada, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1085 · Cited by 48
“MHC II, Ii, and DM are partially coregulated (15) and their relative levels are relevant to the constitution of the final peptide pool bound to class II.”
BackgroundClass II Transactivator Is Required for Maximal Expression of HLA-DOB in B Cells
Nagarajan, U. M., Lochamy, J., Chen, X., Beresford, G., Nilsen, R., Jensen, P. E., & Boss, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1780 · Cited by 42
Kretsovali, A., Spilianakis, C. G., Dimakopoulos, A. C., Makatounakis, T., & Papamatheakis, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103164200 · Cited by 51
Hepatic Gene Expression in Morbidly Obese Women: Implications for Disease Susceptibility
Elam, M. B., Cowan, G. S. M., Rooney, R. J., Hiler, M. L., Yellaturu, C. R., Deng, X., Howell, G., Park, E. A., Gerling, I., Patel, D., et al. (2009) · Obesity · doi:10.1038/oby.2009.49 · Cited by 46
“Expression of the major histocompatibility Class II genes is induced by cytokines, in particular IFN-γ (35).”
BackgroundPuvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M. L., Schmelz, M., Glinsmann‐Gibson, B., Miller, T. P., Maddox, A., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1135431 · Cited by 41
“treatment in most cell types.[11] In human cells, CIITA expression is regulated by four promoters referred to as”
BackgroundVelásquez, L. N., Milillo, M. A., Delpino, M. V., Trotta, A., Fernández, P. M., Pozner, R. G., Lang, R., Balboa, L., Giambartolomei, G. H., & Barrionuevo, P. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0416-196r · Cited by 43
Characterization of immunomodulatory responses induced by manuka honey
Masad, R. J., Nasser, R. A., Bashir, G. H., Mohamed, Y. A., Al-Sbiei, A., Al-Saafeen, B. H., Fernández-Cabezudo, M. J., & al-Ramadi, B. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020574 · Cited by 45
The GTP-Binding Domain of Class II Transactivator Regulates Its Nuclear Export
Raval, A., Weissman, J. D., Howcroft, T. K., & Singer, D. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.922 · Cited by 42
“transcription of the CIITA gene in response to IFN- (4, 6).”
BackgroundFeng, X. M., Chen, X., Liu, N., Chen, Z., Zhou, Y. L., Han, Z. B., Zhang, L., & Han, Z. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.10.004 · Cited by 43
Piskurich, J. F., Gilbert, C. A., Ashley, B. D., Zhao, M., Chen, H., Wu, J., Bolick, S. C. E., & Wright, K. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.05.005 · Cited by 41
“Both constitutive and IFN-γ-inducible expression of MHC II are directly controlled by CIITA (Steimle et al., 1993;Steimle et al. 1994;Chang et al., 1994,Chin et al., 1994).”
BackgroundLysosomal Cysteine Proteases and Antigen Presentation
Rudensky, A. Y., & Beers, C. (2006) · Springer eBooks · doi:10.1007/3-540-37673-9_5 · Cited by 41
Potentiation by Thyroid Hormone of Human IFN-γ-Induced HLA-DR Expression
Lin, H., Martino, L. J., Wilcox, B. D., Davis, F. B., Gordinier, J., & Davis, P. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.843 · Cited by 61
Transcriptional control of MHC genes in fetal trophoblast cells
van den Elsen, P. J., Gobin, S. J. P., van der Stoep, N., Datema, G., & Viëtor, H. E. (2001) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(01)00115-2 · Cited by 40
Li, Y.-R., Dunn, Z. S., Garcia, G., Carmona, C., Zhou, Y., Lee, D. P. H., Yu, J., Huang, J., Kim, J. T., Arumugaswami, V., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02787-2 · Cited by 42
The Expression of MHC Class II Genes in Macrophages Is Cell Cycle Dependent
Xaus, J., Comalada, M., Barrachina, M., Herrero, C., Goñalons, E., Soler, C., Lloberas, J., & Celada, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6364 · Cited by 47
“The expression of these transcription factors is ubiquitous and is not regulated by IFN- g. However, the correct expression of MHC class II genes requires the presence of CIITA, a trans-activator that does not bind directly to the DNA, is tissue specific, and whose expression is regulated by IFN-g in macrophages ( 44…”
BackgroundNaamane, H., Maataoui, O. E., Ailal, F., Barakat, A., Bennani, S., Najib, J., Hassar, M., Saı̈le, R., & Bousfiha, A. A. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1179-6 · Cited by 39
Rohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.886 · Cited by 61
Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma
Lv, L., Zhang, Y., Zhao, Y., Wei, Q., Zhao, Y., & Yi, Q. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.704344 · Cited by 47
Mechanisms of paresthesias arising from healthy axons
Mogyoros, I., Bostock, H., & Burke, D. J. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200003)23:3<376::aid-mus9>3.0.co;2-2 · Cited by 79
Effector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37
Novel insights into NOD-like receptors in renal diseases
Jin, J., Zhou, T.-J., Ren, G., Cai, L., & Meng, X. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00886-7 · Cited by 39
The phagosome and redox control of antigen processing
Ewanchuk, B. W., & Yates, R. M. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.040 · Cited by 42
Regulation of MHC class II expression in the central nervous system
Collawn, J. F., & Benveniste, E. N. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00228-2 · Cited by 44
Epigenetic Regulation during B Cell Differentiation Controls CIITA Promoter Accessibility
Green, M. R., Yoon, H., & Boss, J. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3865 · Cited by 35
Quan, V. A., Towey, M., Sacks, S. H., & Kelly, A. P. (1999) · Immunogenetics · doi:10.1007/s002510050579 · Cited by 37
“In contrast expression of CIITA, the class II transactivator protein correlates precisely with MHC class II gene transcription (Chang et al. 1994, 1995b; Otten et al. 1998; Steimle et al. 1994 ).”
BackgroundNPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression
Wang, X., Chai, Y., Quan, Y., Wang, J., Song, J., Zhou, W., Xu, X., Xu, H., Wang, B., & Cao, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01618-6 · Cited by 51
Huang, X., Lüdke, A., Dhingra, S., Guo, J., Sun, Z., Zhang, L., Weisel, R. D., & Li, R. (2016) · The FASEB Journal · doi:10.1096/fj.201600331r · Cited by 39
The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells
Harryvan, T. J., de Lange, S., Hawinkels, L. J. A. C., & Verdegaal, E. M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010137 · Cited by 45
“Nonprofessional APCs can present exogenous antigens on both MHCI and MHCII and thus influence both CD8+ and CD4+ T cell function, although MHCII is usually only expressed under inflammatory conditions [5].”
BackgroundKono, M., Komatsuda, H., Yamaki, H., Kumai, T., Hayashi, R., Wakisaka, R., Nagato, T., Ohkuri, T., Kosaka, A., Ohara, K., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2021619 · Cited by 38
Kanazawa, S., Ota, S., Sekine, C., Tada, T., Otsuka, T., Okamoto, T., Sønderstrup, G., & Peterlin, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606450103 · Cited by 36
Holtz, R., Choi, J. C., Petroff, M. G., Piskurich, J. F., & Murphy, S. P. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.103.017103 · Cited by 36
Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells
Waldburger, J., Rossi, S. W., Holländer, G. A., Rodewald, H.-R., Reith, W., & Acha‐Orbea, H. (2003) · Blood · doi:10.1182/blood-2002-06-1855 · Cited by 45
“1 wt) ( 2) ( 2) ( 2) ( 2) (21, 12) (10, 18)”
PPARgamma--an important regulator of monocyte/macrophage function.
von Knethen, A., & Brüne, B. (2003) · PubMed · Cited by 39
Goodwin, B. L., Huang, X., Tejiram, R., Eason, D. D., Ghosh, N., Wright, K. L., Nagarajan, U. M., Boss, J. M., & Blanck, G. (2001) · PubMed · Cited by 38
Human Leukocyte Antigens in Pregnancy and Preeclampsia
Aisagbonhi, O. A., & Morris, G. P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.884275 · Cited by 44
Rapid recruitment and IFN-I–mediated activation of monocytes dictate focal radiotherapy efficacy
Tadepalli, S., Clements, D. R., Saravanan, S., Hornero, R. A., Lüdtke, A., Blackmore, B., Paulo, J. A., Gottfried‐Blackmore, A., Seong, D., Park, S., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add7446 · Cited by 39
Cohesin Regulates MHC Class II Genes through Interactions with MHC Class II Insulators
Majumder, P., & Boss, J. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100688 · Cited by 35
Li, J.-M., Southerland, L. T., Hossain, M. S., Giver, C. R., Wang, Y., Darlak, K. A., Harris, W. B., Waschek, J. A., & Waller, E. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100686 · Cited by 35
Kulkarni, A., Ganesan, P., & O’Donnell, L. A. (2016) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s40497 · Cited by 47
Greer, S. F., Harton, J. A., Linhoff, M. W., Janczak, C. A., Ting, J. P. ‐., & Cressman, D. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.376 · Cited by 35
“For example, the expression of MHC class II genes is stimulated by IFN- via activation of the Janus kinases through Stat1 and IFN regulatory factor-1 activation of CIITA expression (1, 41, 42).”
BackgroundSiegrist, C., Martínez-Soria, E., Kern, I., & Mach, B. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1793 · Cited by 35
Martin, B. K., Frelinger, J. G., & Ting, J. P. ‐. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6663 · Cited by 39
Kovats, S., Nepom, G. T., Coleman, M., Nepom, B. S., Kwok, W. W., & Blum, J. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118023 · Cited by 35
Rodríguez‐Gil, A., Ritter, O., Saul, V. V., Wilhelm, J., Yang, C.-Y., Grosschedl, R., Imai, Y., Kuba, K., Kracht, M., & Schmitz, M. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-03708-7 · Cited by 38
IK cytokine ameliorates the progression of lupus nephritis in MRL/lprmice
Muraoka, M., Hasegawa, H., Kohno, M., Inoue, A., Miyazaki, T., Terada, M., Nose, M., & Yasukawa, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22172 · Cited by 34
Bomble, M., Tacke, F., Rink, L., Kovalenko, E., & Weiskirchen, R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.094 · Cited by 39
Revel, M., Chebath, J., Mangelus, M., Harroch, S., & Moviglia, G. A. (1995) · Multiple Sclerosis Journal · doi:10.1177/1352458519950101005 · Cited by 38
Aberrant Expression of Fas Ligand in Mice Deficient for the MHC Class II Transactivator
Gourley, T. S., Patel, D. R., Nickerson, K. M., Hong, S., & Chang, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4414 · Cited by 36
“CIITA is critical for both the constitutive as well as the IFN- -induced MHC class II expression (2, 3).”
BackgroundDouhan, J., Lieberson, R., Knoll, J. H. M., Zhou, H., & Glimcher, L. H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1885 · Cited by 34
“It has also been shown that CIITA is responsible for the induction of class II genes by IFN-g in cultured fibroblasts (35, 36).”
BackgroundZeiner, P. S., Zinke, J., Kowalewski, D. J., Bernatz, S., Tichy, J., Ronellenfitsch, M. W., Thorsen, F., Berger, A., Forster, M.-T., Müller, A., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0521-5 · Cited by 34
“inducible HLA-DR expression on cancer cells [36, 44, 56].”
Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
Santambrogio, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878271 · Cited by 35
Miller, D. M., Cebulla, C. M., & Sedmak, D. D. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59421-2_10 · Cited by 35
Nagarajan, U. M., Peijnenburg, A., Gobin, S. J. P., Boss, J. M., & van den Elsen, P. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3666 · Cited by 34
“Expression of exogenous CIITA via plasmid transfection results in the induction of MHC class II expression of all three isotypes in many cell types (47, 57).”
BackgroundChano, F., & Descoteaux, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<2800::aid-immu2800>3.0.co;2-5 · Cited by 10
Collinge, M., Pardi, R., & Bender, J. R. (1998) · PubMed · Cited by 32
Toxoplasma gondii and MHC-restricted antigen presentation: on degradation, transport and modulation
Lüder, C. G. K., & Seeber, F. (2001) · International Journal for Parasitology · doi:10.1016/s0020-7519(01)00260-0 · Cited by 32
Xi, H., & Blanck, G. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(02)00214-6 · Cited by 31
Structural basis of the subcortical maternal complex and its implications in reproductive disorders
Chi, P., Ou, G., Qin, D., Han, Z., Li, J., Xiao, Q., Gao, Z., Xu, C., Qi, Q., Liu, Q., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01153-x · Cited by 31
Graziano, F., Aimola, G., Forlani, G., Turrini, F., Accolla, R. S., Vicenzi, E., & Poli, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-32451-w · Cited by 36
Xu, Y., Harton, J. A., & Smith, B. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707180200 · Cited by 34
Nakayama, A., Murakami, H., Maeyama, N., Yamashiro, N., Sakakibara, A., Mori, N., & Takahashi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209574200 · Cited by 31
Takagi, M., Takakubo, Y., Pajarinen, J., Naganuma, Y., Oki, H., Maruyama, M., & Goodman, S. B. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.004 · Cited by 35
“NLRA CIITA MHC class II expression IFNg [108]”
BackgroundDefinition of a novel complementation group in MHC class II deficiency
Peijnenburg, A., Godthelp, B. C., van Boxel-Dezaire, A. H. H., & van den Elsen, P. J. (1995) · Immunogenetics · doi:10.1007/bf00172153 · Cited by 31
IFN-γ-rich environment programs dendritic cells toward silencing of cytotoxic immune responses
Švajger, U., Obermajer, N., & Jeras, M. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112589 · Cited by 30
Ramia, E., Chiaravalli, A. M., Eddine, F. B. N., Tedeschi, A., Sessa, F., Accolla, R. S., & Forlani, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1548243 · Cited by 33
7‐Interferon‐regulated chaperone governs human lymphocyte antigen class II expression
Kämper, N., Franken, S., Temme, S., Koch, S., Bieber, T. R. M., & Koch, N. (2011) · The FASEB Journal · doi:10.1096/fj.11-189670 · Cited by 30
MHC structure and function – antigen presentation. Part 1
Goldberg, A. C., & Rizzo, L. V. (2015) · Einstein (São Paulo) · doi:10.1590/s1679-45082015rb3122 · Cited by 30
Gameiro, S. F., Ghasemi, F., Barrett, J. W., Nichols, A. C., & Mymryk, J. S. (2019) · Cancers · doi:10.3390/cancers11081129 · Cited by 33
“Expression of MHC-II genes and related genes are restricted to APCs, however nonhematopoietic cells such as fibroblasts, endothelial cells, and epithelial cells can be stimulated by IFNγ to express MHC-II molecules and related proteins involved in the antigen presentation pathway [28,29,36].”
BackgroundInfluentialSartoris, S., Tosi, G., Barbaro, A. D. L., Cestari, T., & Accolla, R. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261028 · Cited by 30
Montani, V., Taniguchi, S., Shong, M., Suzuki, K., Ohmori, M., Giuliani, C., Napolitano, G., Saji, M., Fiorentino, B., Reimold, A. M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.1.5673 · Cited by 30
“This is consistent with the possibility that CIITA is an intermediate factor in the g-IFN-mediated increase of class II gene expression (5, 6, 21, 23, 24), albeit not solely responsible for all the actions of g-IFN as evidenced by differences in the influence of TSH on each of their activities.”
The tumor immune microenvironments of HPV + and HPV − head and neck cancers
Gameiro, S. F., Evans, A. M., & Mymryk, J. S. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1539 · Cited by 39
Lee, E.-Y., Schultz, K. L. W., & Griffin, D. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076412 · Cited by 33
“A variety of cytokines regulate expression of MHC-I, but IFNgamma has a particularly important role in regulation of MHC-II through induction of CIITA [48,77].”
BackgroundZehbe, I., Höhn, H., Pilch, H., Neukirch, C., Freitag, K., & Maeurer, M. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21226 · Cited by 29
“Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.”
BackgroundInfluentialRepression of Major Histocompatibility Complex Genes by a Human Trophoblast Ribonucleic Acid
Peyman, J. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.1.23 · Cited by 28
PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA
Yoon, H., & Boss, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000079 · Cited by 29
Mitogen-activated Protein Kinase ERK1/2 Regulates the Class II Transactivator
Voong, L. N., Slater, A. R., Kratovac, S., & Cressman, D. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706487200 · Cited by 31
Croce, M., Ambrosis, A. D., Corrias, M. V., Pistoia, V., Occhino, M., Meazza, R., Giron‐Michel, J., Azzarone, B. G., Accolla, R. S., & Ferrini, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207054 · Cited by 29
“MHC-II molecule expression in most nonimmune cells can be induced by different stimuli, among which the most potent is IFN-g (Collins et al., 1984; Blanck et al., 1990; Glimcher and Kara, 1992; Steimle et al., 1994).”
BackgroundThe effect on MHC class II expression and apoptosis in placenta by IFNγ administration
Liu, Z., Chen, Y., Yang, Y., & Peng, J. (2002) · Contraception · doi:10.1016/s0010-7824(01)00277-3 · Cited by 28
Metadata
- Authors
- Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B.
- Affiliations
- University of Geneva (CH)
- Jeantet Laboratory of Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland.
- INSERM U132, Hôpital des Enfants Malades, 15015 Paris, France.
- Venue
- Science
- Published
- 1994-07
- Volume
- 265
- Issue
- 5168
- Pages
- 106-109
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060320549
- Cited by
- 898
- References
- 29
- Citations by year
- 2026: 33 · 2025: 35 · 2024: 39 · 2023: 49 · 2022: 35 · 2021: 32 · 2020: 25 · 2019: 20 · 2018: 22 · 2017: 19 · 2016: 27 · 2015: 21 · 2014: 18 · 2013: 13 · 2012: 29
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MHC class II expression, interferon-gamma, CIITA, MHC class II deficiency, gene expression regulation, transcriptional activation
- MeSH terms
- Histocompatibility Antigens Class II, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 16, Fibroblasts, Gene Expression Regulation, Genes, MHC Class II, Humans, Interferon-gamma, Models, Genetic, Nuclear Proteins, RNA, Messenger, Transfection, Tumor Cells, Cultured, Trans-Activators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.